A Study Called VICTORIA to Learn More About How Well Larotrectinib Works in Adults With TRK Fusion-positive Cancer by Comparing Larotrectinib Data From Clinical Studies With Data of Other Treatments From Actual Practice

Clinical trial NCT05192642 · COMPLETED

Trial details

NCT number: NCT05192642
Sponsor: Bayer
Status: COMPLETED
Study type: OBSERVATIONAL

Solid Tumors Harboring NTRK Fusion

Start date: 2021-12-03
Primary completion: 2023-08-31
Enrollment: 368

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.